Avatar

Ishizu

@ishizuishitar

Avatar
reblogged
Avatar
biomedicool

Thymus

The thymus is a specialised primary lymphoid organ of the immune system. 

  • At its largest and most active during the neonatal and pre-adolescent periods. 
  • Decreases in size and activity through teenage years
  • Thymus tissue is gradually replaced by adipose tissue (fat). 
  • Residual T lymphopoiesis continues throughout adult life.

The thymus is composed of two identical lobes and is located in the anterior superior mediastinum, in front of the heart and behind the sternum. Each lobe of the thymus can be divided into a central medulla and a peripheral cortex which is surrounded by an outer capsule.

Function

Facilitates the maturation of T cells - which provide cell-mediated immunity.

  • T cells begin as hematopoietic precursors from the bone-marrow, and migrate to the thymus, where they are referred to as thymocytes
  • In the thymus they undergo a process to ensure the cells react against antigens (“positive selection”), but that they do not react against antigens found on body tissue (“negative selection”).
  • Once mature, T cells emigrate from the thymus to provide vital functions in the immune system.
  • Each T cell has a distinct T cell receptor, suited to a specific substance, called an antigen.
  • Most T cell receptors bind to the major histocompatibility complex on cells of the body. 

Positive selection

T cells have distinct T cell receptors. These  are formed by process recombination gene rearrangement which is error-prone, and some thymocytes fail to make functional T-cell receptors, whereas other thymocytes make T-cell receptors that are autoreactive. The survival and nature of the T cell then depends on its interaction with surrounding thymic epithelial cells

  • T cell receptor interacts with the MHC molecules on the surface of epithelial cells.
  •  A T cell with a receptor that doesn’t react, or reacts weakly will die by apoptosis. 
  • A T cell that does react will survive and proliferate.
  • A mature T cell expresses only CD4 or CD8, but not both.

Negative selection

T cells that attack the body’s own proteins are eliminated in the thymus. Epithelial cells in the medulla and dendritic cells in the thymus express major proteins from elsewhere in the body. Some CD4 positive T cells exposed to self antigens persist as T regulatory cells.

Pathology

Immunodeficiency - As the thymus is the organ of T-cell development, any congenital defect in thymic genesis or a defect in thymocyte development can lead to a profound T cell deficiency in primary immunodeficiency disease.

Autoimmune disease - Genetic disorders, such as Myasthenia gravis: caused by antibodies that block acetylcholine receptors.

Thymomas - Originate in thymic epithelial cells most often in adults older than 40. Generally detected when they cause symptoms, such as a neck mass or affecting nearby structures such as the superior vena cava. Can be benign; benign but by virtue of expansion, invading beyond the capsule of the thymus (“invasive thyoma”), or malignant (a carcinoma).

Lymphomas - Tumours originating from T cells of the thymus form a subset of acute lymphoblastic leukaemia (ALL)

Thymic cysts - The thymus may contain cysts, usually less than 4 cm in diameter. Thymic cysts are usually detected incidentally and do not generally cause symptoms.

Avatar
reblogged
Avatar
biomedicool

Tonsilitis

Tonsillitis is inflammation of the pharyngeal tonsils.

  • Inflammation usually extends to the adenoid and the lingual tonsils
  • Most commonly viral
  • Most cases of bacterial tonsillitis are caused by group A beta-hemolytic Streptococcus pyogenes (GABHS) - strep throat.
  • Spread through the air.

Symptoms may include sore throat, fever, enlargement of the tonsils, trouble swallowing, and large lymph nodes around the neck. Complications include peritonsillar abscess.

Image

Recurrent tonsillitis

  • A polymicrobial flora consisting of both aerobic and anaerobic bacteria 
  • Other competing bacteria are reduced - less interference to GABHS infection. 
  • Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae are the most common bacteria isolated in recurrent tonsillitis, and Bacteroides fragilis is the most common anaerobic bacterium isolated in recurrent tonsillitis.
  • The microbiologies of recurrent tonsillitis in children and adults are different; adults show more bacterial isolates, with a higher recovery rate of Prevotella species, Porphyromonas species, and B fragilis organisms , whereas children show more GABHS. Also, adults more often have bacteria that produce beta-lactamase.

Chronic tonsillitis

  • Polymicrobial bacterial population present
  • There is likely a relationship between tonsillar size and chronic bacterial tonsillitis based on both the aerobic bacterial load and the absolute number of B and T lymphocytes. 
  • Fewer dendritic cells on the surface epithelium and more in the crypts and extrafollicular areas during chronic tonsillitis. 
  • Radiation exposure may relate to the development of chronic tonsillitis. A high prevalence of chronic tonsillitis was noted following the Chernobyl nuclear reactor accident in the former Soviet Union.
Avatar
reblogged
Avatar
biomedicool

Tonsils

The tonsils are a set of lymphoid organs consisting of the adenoid tonsil, two tubal tonsils, two palatine tonsils, and the lingual tonsils. These organs play an important role in the immune system.

Palatine tonsil

  • Main tonsils
  • Non-keratinized stratified squamous epithelium
  • Incompletely encapsulated
  • Long, branched crypts
  • Located on sides of oropharynx between palatoglossal and palatopharyngeal arches
  • Reach their largest size in puberty, and they gradually undergo atrophy 

Adenoid (also termed “pharyngeal tonsil”)

  • Ciliated pseudostratified columnar epitheium (respiratory epithelium)
  • Incompletely encapsulated
  • No crypts, but small folds
  • Located on roof of pharynx

Tubal tonsils

  • Ciliated pseudostratified columnar epithelium (respiratory epithelium)
  • Located on roof of pharynx

Lingual tonsils

  • Non-keratinized stratified squamous epithelium
  • Incompletely encapsulated
  • Long, unbranched crypts
  • Located behind terminal sulcus (tongue)

The tonsils serve as the immune system’s first line of defence against ingested or inhaled foreign pathogens. 

  • The tonsils have specialised antigen capture cells (M cells) on their surface that allow for the uptake of antigens produced by pathogens.
  • These M cells then alert the underlying B cells and T cells in the tonsil that a pathogen is present and an immune response is stimulated.
  • B cells are activated and proliferate in areas called germinal centres in the tonsil. 
  • Secretory antibody (IgA) is produced.
  • Studies suggest that the tonsils also produce T cells themselves, in a manner similar to the thymus.
Avatar
reblogged
Avatar
biomedicool

Thalidomide

Thalidomide was originally introduced as a non-barbiturate sedative in 1957 and later marketed for the treatment of nausea in pregnant women by the German company Chemie Grünenthal, as antiemetic properties were discovered. In the 1960s however it became apparent that thalidomide treatment resulted in severe teratogenic birth defects and from November 1961 it began to be withdrawn worldwide. It has since been reintroduced into a number of studies and treatments due to its immunosuppresive and anti-angiogenic activity.

  Chemical structure of thalidomide. Thalidomide is a stereo-isomer and can exist, depending on the state of the chiral carbon, in two enantiomeric states. Both R and S can interconvert in body fluids and tissues.  Thalidomide was distributed as a racemic mix of both enantiomers.

  • Thalidomide is a piperidinyl isoindole and synthetic derivative of glutamic acid, consisting of two linked glutarimide and pthalimide rings. 
  • The unstable chiral carbon allows two enantiomers to coexist - the S-enantiomer being teratogenic (Franks, 2004.) 
  • The mechanism of action that resulted in these teratogenic effects is still not fully understood. 
  • Leading theories focus on thalidomide’s antiangiogenic properties; ability to induce cell death and generate reactive oxygen species; and Cereblon, a thalidomide-binding protein and primary source of teratogenic action (Takumi, 2010). 
  • Thalidomide is hydrolyzed in bodily fluids and metabolized in the liver by cytochrome p450.

When first developed thalidomide was deemed so non-toxic that an LD50 could not be established, but tragically an estimated 25,000 babies were born severely impaired and a further 123,000 miscarried or stillborn (Johnson, 2016).

Antiangiogenic properties 

Thalidomide has the ability to inhibit angiogenic vascularization in embryos, thus carrying out teratogenic damage. 

  • The bulk of its damage occurs in days 20-36 of fertilization. 
  • During this time, the primitive vessels formed by vasculoneogensis mature and begin to proliferate and migrate in response to signals and growth factors such as FGF. 
  • It is thought that analogues of thalidomide could block a number of these signals, thus preventing embryonic vascular development outwards towards the limbs and resulting in limb deformities such as phocemelia. 

Molecular targets of thalidomide

Cereblon 

  • Forms part of a ubiquitination complex with DNA Binding Protein 1, which in turn selects molecules for destruction. 
  • Thalidomide binds, preventing formation of the complex and proper regulation of developmental signaling molecules, thus initiating teratogenis by inhibiting angiogenesis (Takumi, 2010). 
  • Could also degrade some proteins and prevent breakdown of others.

Tubulin 

  • part of the cytoskeleton and  required for cell proliferation and formation of  new vessels in the embryo. 
  • When bound by the 5HPP-33 thalidomide analogue, cytoskeletal dynamics are altered preventing cell division. 
  • This could prevent cell proliferation and migration and consequently tissue morphogenesis, the severity of which would be dependent on vascular and tissue maturation at the point of contact with thalidomide (Vergesson, 2015).
Avatar
reblogged
Avatar
biomedicool

Amphetamines

Amphetamines are sympathomimetic amines which mimic the structures of the catecholamine neurotransmitters, noradrenaline and dopamine.

  • They are substrates for the neuronal plasma membrane monamine uptake transporters DAT and NET (dopamine and norepinephrine transporters)
  • Thus act as competitive inhibitors, reducing the reuptake of dopamine and noradrenaline. 
  • In addition, they enter nerve terminals via the uptake processes or by diffusion and interact with the vesicular monoamine pump VMAT-2 to inhibit the uptake into synaptic vesicles of cytoplasmic dopamine and noradrenaline
  • The amphetamines are taken up into the storage vesicles by VMAT-2 and displace the endogenous monamines from the vesicles into the cytoplasm. 
  • At high concentrations amphetamines can inhibit monoamine oxidase, which otherwise would break down cytoplasmic monamines.

The cytoplasmic monoamines can then be transported out of the nerve endings via DAT and NET transporters working in reverse, a process thought to be facilitated by amphetamine binding to the transporters. The concentration of extracellular dopamine and noradrenaline is therefore increased, and the reward response generated by increased activation of dopamine receptors can eventually lead to addiction.

The biggest problem facing addiction is the lack of effective medical treatment available. Currently, therapeutic strategies involve giving the patient something similar, but less potent than the drug of addiction, in an attempt to slowly reach abstinence with minimal withdrawal. However, due to memory and learning mechanisms as well as epigenetic and transcriptional changes, relapse is not uncommon. 

Pharmacology is less scary than it looks but hard to understand just through reading - here’s a great video

Avatar
reblogged
Avatar
biomedicool

My heart skip skips a beat

HEARTBEATS!!

The pause is to allow the atria to fully empty into the ventricle.

Heartbeat on an ECG trace

P Interval (Ventricular Diastole)
  • Atria and ventricles are relaxed
  • blood is flowing into the atria from the veins. 
  • Atrial pressure increases above that of the ventricle, AV valves open allowing blood to flow into the ventricle
P Wave (Atrial Systole) P-Q

Signal transduction from SA to AV nodes. 

  • SA node fires 
  • Atria contract causing atrial systole 
  • which forces all blood into the ventricles
  • emptying the atria.
Q Interval (End of Ventricular Diastole)

Depolarisation of interventricular (IV) septum 

  • AV valves remain open - all remaining blood squeezed into the ventricles. 
  • impulse from the SA node reaches the AV node 
  • which spreads the signal throughout the walls of the ventricles via bundles of His and Purkinje fibres
  • R peak is the end of ventricular diastole and the start of systole.
R Interval (Ventricular Systole)

Ventricular contraction

  • All blood is now within the ventricles
  • so pressure is higher than in the atria - AV valves close
  • ventricles start to contract although pressure is not yet high enough to open the SL (semilunar) valves
ST Segment (Ventricular Systole)

Ventricular contraction

  • Pressure increases until it equals Aortic pressure,
  • SL valves open
  • blood is ejected into the Aorta (and pulmonary artery) as ventricles contract
  • At this time the atria are in diastole and filling with blood returning from the veins.
  • plateau in ventricular arterial pressure
T Wave (Ventricular Diastole)

T= moment of Ventricular repolarisation immediately before ventricular relaxation

  • Ventricles relax
  • ventricular pressure is once again less than the aortic pressure 
  • so SL valves close
Avatar
reblogged
Avatar
biomedicool

Galactosaemia

Galactosaemia describes the presence of galactose in the blood. Galactose is a sugar which mainly comes from lactose, the sugar found in milks. Lactose is normally broken down into the two simple sugars, galactose and glucose. The galactose is then broken down further and used in many parts of the body including the brain. 

  • Galactosaemia is an autosomal recessive deficiency in enzyme (galactose-1-phosphate uridyltransferase) responsible for galactose metabolism
  • Causes build up of galactose in tissues

Symptoms:

Pathogeneseis:

  • Galactose-1-phosphate uridyltransferase converts Galactose-1-phosphate and UDPglucose to UDPgalactose and Glucose-1-phosphate. This can continue down the normal galactose metabolism pathway. 
  • Galactosaemia = deficiency in galactose-1-phosphate uridyltransferase. Galactose-1-phosphate accumulates. 
  • G1P is extremely toxic.
  • Accumulation of G1P means polyol pathway of carbohydrate metabolism takes place
  • Aldose reductase reduces galactose to sugar alcohol galactitol.
  • Galactitol is not suitable substrate for next enzyme in the pathway; polyol dehydrogenase. 
  • Galactitol accumulates (excreted in urine). 
  • Galactitol is responsible for many negative effects. E.g. osmotic effects - causes lens swelling and hence cataracts.
  • Accumulated galactose can also be oxidated to galactonate. 
  • Galactonate can be used in the pentose phosphate pathway, so is less harmful. 

Other types:

  • UDP-galactose to UDP-glucose catalysed by UDP-galactose-4 epimerase. Lack of this enzyme is Type 3. 
  • Galactose to Galactose-1-phosphate catalysed by galactokinase. Lack of galactokinase is type 2. 

If untreated, macrovesicular steatosis is commonly reported, with evolution to fibrosis and cirrhosis, instead of glycogen accumulation. In more recent studies, young rats fed with galactose exhibit similar histopathological modification in the liver and suggest that oxidative stress has an important role in liver dysfunction.

.

Avatar
reblogged
Avatar
biomedicool

Kidney function tests

Creatinine

  • Creatinine is a waste product produced in muscles from the breakdown of a creatine. 
  • Creatine is part of the cycle that produces energy needed to contract  muscles. 
  • Both creatine and creatinine are produced at a relatively constant rate. 
  • Almost all creatinine is excreted by the kidneys, so blood levels are a good measure of how well your kidneys are working.

If low: 

  • Low levels are not common and are not usually a cause for concern. 
  • As creatinine levels are related to the amount of muscle the person has, low levels may be a consequence of decreased muscle mass (such as in the elderly) but may also be occasionally found in advanced liver disease.

If high:  

  • Kidneys break down creatinine - if levels are high, they’re not working properly –>
  • Damage to or swelling of blood vessels in the kidneys (glomerulonephritis) caused by, eg, infection or autoimmune diseases bacterial infection of the kidneys (pyelonephritis)
  • Death of cells in the kidneys’ small tubes (acute tubular necrosis) caused, for example, by drugs or toxins
  • Prostate disease, kidney stone, or other causes of urinary tract obstruction.
  • Reduced blood flow to the kidney due to shock, dehydration, congestive heart failure, atherosclerosis, or complications of diabetes

Creatinine blood levels can also increase temporarily as a result of muscle injury and are generally slightly lower during pregnancy.

Urea

Urea is the final breakdown product of the amino acids found in proteins. Nitrogen in the form of ammonia is produced in the liver when protein is broken down. The nitrogen combines with other chemicals in the liver to form the waste product urea.  Healthy kidneys remove more than 90% of the urea the body produces.

If Low: 

  • Low urea levels are not common and are not usually a cause for concern. They can be seen in severe liver disease or malnutrition but are not used to diagnose or monitor these conditions. Low urea levels are also seen in normal pregnancy.

·   If high: 

  • High urea levels suggest poor kidney function. 
  • Acute or chronic kidney disease. 
  • However, there are many things besides kidney disease that can affect urea levels such as decreased blood flow to the kidneys as in congestive heart failure, shock, stress, recent heart attack or severe burns; bleeding from the gastrointestinal tract; conditions that cause obstruction of urine flow; or dehydration.

Albumin

Albumin is the most abundant protein in the blood. It keeps fluid from leaking out of blood vessels; nourishes tissues; and transports hormones, vitamins, drugs, enzymes, and ions like calcium throughout the body. Albumin is made in the liver and is extremely sensitive to liver damage. 

If low:

  • Low albumin concentrations in the blood can suggest liver disease. Liver enzyme tests are requested to help determine which type of liver disease.
  • Diseases in which the kidneys cannot prevent albumin from leaking from the blood into the urine and being lost.
  • Also seen in severe inflammation or shock.
  • Conditions in which the body does not properly absorb and digest protein such as Crohn’s disease.

If high: 

  • High albumin concentrations in the blood usually reflect dehydration.

This is a very long list so click keep reading to read the rest!

Avatar
reblogged
Avatar
biomedicool

Liver function tests

AST/ALT ratio

If AST is higher than ALT, a muscle source of these enzymes should be considered. For example, muscle inflammation due to dermatomyositis may cause AST>ALT. Or complete liver necrosis 

  • Alcoholic fatty liver disease: AST > 8 times the ULN; ALT > 5 times the ULN
  • Nonalcoholic fatty liver disease: AST and ALT > 4 times the ULN
  • Acute viral hepatitis or toxin-related hepatitis with jaundice: AST and ALT > 25 times the ULN
  • Ischemic hepatopathy (ischemic hepatitis, shock liver): AST and ALT > 50 times the ULN (in addition the lactate dehydrogenase is often markedly elevated)
  • Chronic hepatitis C virus infection: Wide variability, typically normal to less than twice the ULN, rarely more than 10 times the ULN
  • Chronic hepatitis B virus infection: Levels fluctuate; the AST and ALT may be normal, though most patients have mild to moderate elevations (approximately twice the ULN); with exacerbations, levels are more than 10 times the ULN
Avatar
reblogged
Avatar
biomedicool

The Liver - Paracetamol Toxicity

Normal metabolism

  • Drug metabolizing enzymes are are located in lipophilic membranes of endoplasmic reticulum (Cytochrome P450 (2E1, 1A2 and 3A4))
  • 95% of paracetamol is conjugated with glucaronic acid or sulphate and excreted in urine. This is non-toxic.
  • 5% is oxidized by the CYPs to form N-acetyl-P-benzoquinone imine (NAPQI), which is toxic.
  • NAPQI is conjugated with glutathione and mercapturic acid and cysteine conjugates and excreted in bile in normal metabolism.

In overdose

  •  the glucaronic acid and sulphate pathways become saturated, so more goes via the NAPQI pathway. 
  • Glutathione stores become depleted as it is consumed by the NAPQI.
  • NAPQI accumulates and begins conjugating hepatic proteins and nucleic acids, including those of the mitochondria. 
  • Enzymes such as glutathione peroxidase, HMG-CoA, become inhibited and radicals begin forming as the mitochondria are damaged.
  • In the cytosol, MAP kinase JNK is activated, which binds to Sab proteins on the outer mitochondrial membrane, which in turn deactivates p-Src on the inner mitochondrial membrane. 
  • This inhibits electron transport
  • More radicals are released and there is more oxidative stress.
  • There is mitochondrial and cell death leading to necrosis if not treated early enough.

Liver function tests:

  • GGT elevated
  • Bilirubin elevated
  • ALP elevated
  • AST and ALT extremely high
  • Becoming higher than 100 times the upper reference limit in toxic ingestion. No other hepatic conditions increase AST/ALT to these levels.
  • Decreased albumin once necrosis forms – many other conditions of the liver don’t reach this stage
Avatar
reblogged
Avatar
biomedicool

COPD

Chronic obstructive pulmonary disease (COPD) is an umbrella term for a group of progressive lung diseases including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis.

  •  All forms of smoke inhalation incur a risk
  • soluble gases are adsorbed in the lungs and particles are deposited in the airways and alveoli
  • Narrowing of the airways from inflammation and fibrotic scarring restricts exhalation
  • resulting in hyperinflation, with restriction defined as an FEV1 /FVC < 0.7
  • Leading to hallmark symptoms of breathlessness and exercise restriction

Symptoms

  • Shortness of breath, especially during physical activities, + chest tightness
  • A chronic cough that may produce mucus (sputum) that may be clear, white, yellow or greenish
  • Blueness of the lips or fingernail beds (cyanosis)
  • Frequent respiratory infections
  • Lack of energy and weight loss 
  • Swelling in ankles, feet or leg (oedema) 

Causes

  • Smoking is the primary risk factor for in high- and moderate-income countries 
  • however in low-income countries indoor air pollution is the leading cause of noxious inhalation 
  • high prevalence of COPD among non-smoking women in parts of the Middle East, Africa and Asia is likely due to long-term exposure to cooking fires 

Pathology

Any inhaled substances (including dust and air pollution) can result in an innate and adaptive immune response in the lungs, with a level of inflammation present in all smokers. 

  • chronic bronchitis from mucous hypersecretion, 
  • emphysema - tissue destruction
  • disruption of the lungs’ repair and defence mechanisms causing bronchiolitis: the fibrosis and inflammation of the small airway. 
  • These changes increase both lung compliance and resistance in the small conducting airways, trapping the air and leading to progressive airflow obstruction. 
  • Chronic bacterial infections are often present as a result of mucus hypersecretion and stasis, which will exacerbate inflammation and consequently disease progression 

Inflammation in the lungs

  • Protease imbalances result in oxidative stress from chronicoxidative substances such as cigarette smoke
  • or from the release of reactive oxygen (ROS) and nitrogen species from inflammatory cells. 
  • This primes neutrophils and macrophages to release a combination of proteases including elastase 
  • Markers of oxidative stress are detectable in stable COPD and asthma (further increased in exacerbations)
  • Antiproteases are simultaneously inactivated by oxidation
  • insufficient inhibition of the elevated proteases
  • which then break down connective tissue leading to emphysema or bronchiectasis. 
  • Oxidative stress also stimulates mucous hypersecretion
  • increasing the numbers of goblet cells and the size of bronchial submucosal glands –> Mucous build up
  • Damages cilia - can no longer move mucous - coughing up mucous (especially in the morning)

Diagnosis

  • Chest X-ray - show emphysema, rule out other lung problems or heart failure.
  • CT scan - detect emphysema, screen for lung cancer.
  • Arterial blood gas analysis -  measures how well lungs perform respiration
  • Laboratory tests - eg for alpha-1-antitrypsin (AAt) deficiency, which can cause COPD.
  • pulmonary function tests - measure lung function, spirometry most common

Treatment

The main treatment for COPD is removal of the causative factor, e.g. smoking. 

  • Bronchodilators (usually inhaler) — relax airways. Helps relieve coughing and shortness of breath 
  • Inhaled or oral corticosteroids reduce airway inflammation and help prevent exacerbations. 
  • Phosphodiesterase-4 inhibitors - decreases airway inflammation and relaxes the airways. Common side effects include diarrhea and weight loss.
  • Antibiotics for respiratory infections
Avatar
reblogged
Avatar
biomedicool

Bladder Cancer

Causes

Smoking 

  • A result of chemical accumulation and formation within the bladder epithelium

Occupational Exposure 

  • Dyes, textiles, rubbers, paints, plastics, leather tanning etc. 
  • Analine dyes, 2-Naphthylamine, 4-aminobiphenyl, xenylamine, benzidine, o-toluidine

Schistosomiasis infection 

  • Co-factors: smoking, diet, bacterial infection

Ketamine use 

  • Ketamine-associated ulcerative cystitis 
  • Direct toxic damage by ketamine or metabolites 
  • Microvascular damage 
  • Trigger of autoimmunity 
  • Unrecognised bacteriuria 

Types of Bladder Cancer 

Transitional cell 

  • 90% of bladder cancers 
  • Can be invasive (in situ) or invasive (grown in to muscle layer) 
  • Arises from transitional cells 
  • Has further subtypes 

Squamous cell 

  • 5% of bladder cancers 
  • Associated with shistosomiasis infection 

Adenocarcinoma of the bladder 

  • 1-2% of bladder cancers 
  • Arises from goblet cells within the bladder 

Other very rare types include soft tissue sarcomas and neuroendocrine tumours.